Answers are grounded in this paper and cite their sources.
Our results showed that three out seven miRNAs, namely hsa-miR-200c-3p, hsa-miR-144-3p and hsa-miR-221-3p were differentially expressed in plasma-derived exosomes from melanoma patients and controls. Furthermore, the expression of the three miRNAs may be a promising ancillary tool as a melanoma biomarker, even for discriminating between nevi and melanoma.
No takes yet. Share an insight, caveat, or question.
Martino et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: